U.S. stock futures Monday morning were building on Friday's rally, with easing geopolitical pressures promoting
a bullish environment for global equities.
Asian markets kicked off a positive overnight session as a result of benign Chinese inflation data, spilling into Europe with encouraging headlines from the Middle East and Eastern Europe driving euro-zone bourses significantly higher.
Over the weekend, the latest ceasefire between Israel and Hamas held, Russia backed off its aggressive actions on the Ukraine border, and U.S. air strikes coupled with Iraqi participation against ISIS were beginning to put a dent in the crisis, all of which encouraged investors to step back into riskier assets.
Dovish comments from Fed Vice Chairman Stanley Fischer added to the bullish tone across Wall Street, especially concerning the U.S. labor market. Fischer expressed concern that a lack of labor participation could ultimately weigh down the economy.
The impact of easing global pressures was seen in the commodity market, where gold was trading slightly lower, oil was unchanged and the yield on the 10-year Treasury note held steady at 2.43%.
-Dow Jones Industrial up 0.46%
-S&P 500 futures up 0.51%
-Nasdaq 100 futures up 0.56%
Nikkei up 2.38%
Hang Seng up 1.29%
Shanghai Composite up 1.38%
FTSE-100 up 0.86%
DAX-30 up 1.64%
PRE-MARKET SECTOR WATCH
(+) Large cap tech: higher
(+) Chip stocks: higher
(+) Software stocks: higher
(+) Hardware stocks: higher
(+) Internet stocks: higher
(+) Drug stocks: higher
(+) Financial stocks: higher
(+) Retail stocks: higher
(+) Industrial stocks: higher
(+) Airlines: mixed
(+) Autos higher
(+) MNKD (+18.82%) Announced deal with Sanofi ( SNY ) for worldwide exclusive licensing agreement for insulin inhaler
(+) PIP (+53.54%) Delaware court Orders SIGA Technologies ( SIGA ) to pay to pay lump sum damages
(+) ACHN (+7.34%) Upgraded to Overweight at Piper Jaffray, price target doubled to $10
(-) SIGA (-28.47%) Delaware court Orders SIGA to pay to pay lump sum damages to PharmAthene (PIP)
(-) PCLN (-1.00%) Beat Q2 earnings estimates, but missing on revenue and guiding Q3 earnings below expectations
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.